Linked Life Data

2408454

Source:http://linkedlifedata.com/resource/pubmed/id/2408454

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1985-7-12
pubmed:abstractText
The improvement of the course of adjuvant arthritis by thymosin led us to use the transfer factor (biological active fraction of the homogenate of human tonsillar leukocytes) in this reported experiment. Transfer factor administered in the amount 200 micrograms (analogy of 10' leukocytes) 3 times a week was able to completely prevent the development of adjuvant arthritis. In the period of maximum development of adjuvant arthritis, symptoms were observed in control rats not treated with transfer factor (on day 21 after complete Freund adjuvants application) while in the transfer factor treated rats, swelling of the paws was not demonstrated and the mobility was the same as in that of the healthy ones. Signs of bone lesions were not present in these animals as well. Transfer factor has only a weak effect on interferon production in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0301-0546
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
17-21
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed:articleTitle
The effects of transfer factor in adjuvant diseases in rats.
pubmed:publicationType
Journal Article